Neoadjuvant treatment with weekly high-dose 5-Fluorouracil as a 24h-infusion, folinic acid and biweekly oxaliplatin in patients with primary resectable liver metastases of colorectal cancer: Long-term results of a phase II trial

Medical Science Monitor

Volumn 16, Issue 2, 2010, Pages

  Boxberger, Frank ^a   Albrecht, Heinz ^a   Konturek, Peter C ^a   Reulbach, Udo ^a   Maennlein, Gudrun ^a   Meyer, Thomas ^a   Hohenberger, Werner ^a   Hahn, Eckhart G ^a   Wein, Axel ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

5 Fluorouracil; Colorectal cancer; Folinic acid; Neoadjuvant treatment; Oxaliplatin; Resectable liver metastases

Indexed keywords

FLUOROURACIL; FOLINATE CALCIUM; FOLINIC ACID; OXALIPLATIN;

ADJUVANT THERAPY; ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONJUNCTIVITIS; CONSTIPATION; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FEVER; FOLLOW UP; HAND FOOT SYNDROME; HISTOPATHOLOGY; HUMAN; IMAGING SYSTEM; LEUKOPENIA; LIVER METASTASIS; MALE; MORBIDITY; MULTIPLE CYCLE TREATMENT; NAUSEA; PAIN; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE COMPLICATION; SENSORIMOTOR NEUROPATHY; STOMATITIS; SURGICAL MORTALITY; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING;

AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; INFUSION PUMPS, IMPLANTABLE; KAPLAN-MEIERS ESTIMATE; LEUCOVORIN; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; ORGANOPLATINUM COMPOUNDS; PATIENT COMPLIANCE; TIME FACTORS;

EID: 76049109203     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Wein A, Riedel C, Brückl W et al: Neoadjuvant treatment with weekly high-dose 5-Fluorouracil as 24-hour infusion, folinic acid and oxaliplatin in patients with primary resectable liver metastases of colorectal cancer. Oncology, 2003; 64: 131-38
2. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics. 2002. CA Cancer J Clin, 2005; 55: 74-108
3. Harlak A, Soran A: Trustworthy alteration and improvement in adjuvant treatment of colon cancer. Med Sci Monit, 2006; 12: RA46-52
4. Ferlay J, Autier P, Boniol M et al: Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol, 2007; 18: 581-92
5. Krebs in Deutschland 2003-2004. Häufigkeiten und Trends. 6. überarbeitete Auflage. Robert-Koch-Institut (Hrsg.) und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (Hrsg.). Berlin, 2008
6. Nordlinger B, Guiguet M, Vaillant JC et al: Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie. Cancer, 1996; 77: 1254-62
7. Scheele J, Stang R, Altendorf-Hofmann A, Paul M: Resection of colorectal liver metastases. World J Surg, 1995; 19: 59-71
8. Fong Y, Cohen AM, Fortner JG et al: Liver resection for colorectal metastases. J Clin Oncol, 1997; 15: 938-46
9. Fong Y, Fortner J, Sun RL et al: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg, 1999; 230: 309-21
10. Nordlinger B, Benoist S: Benefits and risks of neoadjuvant therapy for liver metastases. J Clin Oncol, 2006; 24: 4954-55
11. Lorenz M, Müller HH, Schramm H et al: Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen). Ann Surg, 1998; 228: 756-62
12. Kemeny N, Huang Y, Cohen AM et al: Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med, 1999; 341: 2039-48
13. Kemeny MM, Adak S, Gray B et al: Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy - an intergroup study. J Clin Oncol, 2002; 20: 1499-505
14. de Gramont A, Figer A, Seymour M et al: Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol, 2000; 18: 2938-47
15. Giacchetti S, Perpoint B, Zidani R et al: Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol, 2000; 18: 136-47
16. Saltz LB, Cox JV, Blanke C et al: Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med, 2000; 343: 905-14
17. Douillard JY, Cunningham D, Roth AD et al: Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet, 2000; 355: 1041-47
18. Hurwitz H, Fehrenbacher L, Novotny W et al: Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med, 2004; 350: 2335-42
19. Cunningham D, Humblet Y, Siena S et al: Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med, 2004; 351: 337-45
20. Tsavaris N, Kosmas C, Gennatas K et al: Etoposide added to weekly leucovorin (LV)/5-fluorouracil (5-FU) in LV/5-FU pre-treated patients with advanced colorectal cancer. Med Sci Monit, 2002; 8: PI65-69
21. Wein A, Riedel C, Köckerling F et al: Impact of surgery on survival in palliative patients with metastatic colorectal cancer after first line treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and folinic acid. Ann Oncol, 2001; 12: 1721-27
22. Giacchetti S, Itzhaki M, Gruia G et al: Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol, 1999; 10: 663-69
23. Bismuth H, Adam R, Lévi F et al: Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg, 1996; 224: 509-22
24. André T, Boni C, Mounedji-Boudiaf L et al: Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med, 2004; 350: 2343-51
25. Link K, Happich K, Schirner I et al: Palliative second-line treatment with weekly high-dose 5-fluorouracil as 24-hour infusion and folinic acid (AIO) plus oxaliplatin after pre-treatment with the AIO-regimen in colorectal cancer (CRC). Anticancer Res, 2004; 24: 385-91
26. World Health Organization: WHO handbook for reporting results for cancer treatment. Geneva 1979, WHO Offset Publication, No. 48
27. Greenwood M: The natural duration of cancer. Rep Pub Hlth Med Subj, No. 33. London: HM Stationary Office, 1926
28. Scheele J: Hepatectomy for liver metastases. Br J Surg, 1993; 80: 274-76
29. Van Cutsem E, Nordlinger B, Adam R et al: European Colorectal Metastases Treatment Group. Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. Eur J Cancer, 2006; 42: 2212-21
30. Tomlinson JS, Jarnagin WR, DeMatteo RP et al: Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol, 2007; 25: 4575-80
31. Mitry E, Fields AL, Bleiberg H et al: Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol, 2008; 26: 4906-11
32. Benoist S, Nordlinger B: Neoadjuvant treatment before resection of liver metastases. Eur J Surg Oncol, 2007; 33: S35-41
33. Kronawitter U, Kemeny NE, Heelan R et al: Evaluation of chest computed tomography in the staging of patients with potentially resectable liver metastases from colorectal carcinoma. Cancer, 1999; 86: 229-35
34. Nordlinger B, Sorbye H, Glimelius B et al: EORTC Gastro-Intestinal Tract Cancer Group; Cancer Research UK; Arbeitsgruppe Lebermetastasen und-tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO); Australasian Gastro-Intestinal Trials Group (AGITG); Fédération Francophone de Cancérologie Digestive (FFCD). Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet, 2008; 371: 1007-16